Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 15.25
-1.10 (-6.73%)
Last updated: May 18, 2026, 12:40 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €121.77 million as of May 18, 2026. Its market cap has increased by 402.59% in one year.
Market Cap
121.77M
Enterprise Value
119.57M
Revenue
9.69M
Ranking
n/a
PE Ratio
42.04
Stock Price
€15.25
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 121.77M, an increase of 692.31%. That is a compound annual growth rate of 64.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 121.77M | 89.28% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.42B |
| Laboratorios Farmaceuticos Rovi | 3.04B |
| Almirall | 2.47B |
| Pharma Mar | 1.69B |
| Clínica Baviera | 884.22M |
| Prim, S.A. | 223.73M |
| Laboratorio Reig Jofre | 218.18M |
| Oryzon Genomics | 218.12M |